| Framework for clinical trials in cerebral small vessel disease (FINESSE): a review HS Markus, WM van Der Flier, EE Smith, P Bath, GJ Biessels, E Briceno, ... JAMA neurology 79 (11), 1187-1198, 2022 | 33 | 2022 |
| Neurofilament light chain predicts future dementia risk in cerebral small vessel disease M Egle, L Loubiere, A Maceski, J Kuhle, N Peters, HS Markus Journal of Neurology, Neurosurgery & Psychiatry 92 (6), 582-589, 2021 | 28 | 2021 |
| Prediction of dementia using diffusion tensor MRI measures: the OPTIMAL collaboration M Egle, S Hilal, AM Tuladhar, L Pirpamer, E Hofer, M Duering, J Wason, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (1), 14-23, 2022 | 23 | 2022 |
| PRESERVE: randomized trial of intensive versus standard blood pressure control in small vessel disease HS Markus, M Egle, ID Croall, H Sari, U Khan, A Hassan, K Harkness, ... Stroke 52 (8), 2484-2493, 2021 | 22 | 2021 |
| Determining the OPTIMAL DTI analysis method for application in cerebral small vessel disease M Egle, S Hilal, AM Tuladhar, L Pirpamer, S Bell, E Hofer, M Duering, ... NeuroImage: Clinical 35, 103114, 2022 | 10 | 2022 |
| Association of blood pressure lowering intensity with white matter network integrity in patients with cerebral small vessel disease CP Pflanz, MS Egle, JT O'Brien, RG Morris, TR Barrick, AM Blamire, ... Neurology 99 (17), e1945-e1953, 2022 | 5 | 2022 |
| Visualisation of lenticulostriate arteries using contrast-enhanced time-of-flight magnetic resonance angiography at 7 Tesla CN Osuafor, C Rua, AD Mackinnon, M Egle, P Benjamin, DJ Tozer, ... Scientific Reports 12 (1), 20306, 2022 | 4 | 2022 |
| How often does white matter hyperintensity volume regress in cerebral small vessel disease? RB Brown, DJ Tozer, M Egle, AM Tuladhar, FE de Leeuw, HS Markus International Journal of Stroke 18 (8), 937-947, 2023 | 3 | 2023 |
| Individual markers of cerebral small vessel disease and domain‐specific quality of life deficits J Fernando, RB Brown, H Edwards, M Egle, HS Markus, J Tay Brain and Behavior 11 (5), e02106, 2021 | 3 | 2021 |
| The association of diffusion tensor MRI measures of normal appearing white matter and cognition YL Ng, CS Tan, M Egle, B Gyanwali, DJ Tozer, HS Markus, C Chen, ... Cerebral Circulation-Cognition and Behavior 5, 100174, 2023 | 1 | 2023 |
| Loss of white matter integrity mediates the association between cortical cerebral microinfarcts and cognitive dysfunction: A longitudinal study J Huang, M Oh, C Robert, X Huang, M Egle, DJ Tozer, C Chen, S Hilal Journal of Cerebral Blood Flow & Metabolism, 0271678X241258563, 2024 | | 2024 |
| Association between retinal microvascular abnormalities and late-life brain amyloid-β deposition: the ARIC-PET study M Egle, JA Deal, KA Walker, DF Wong, AR Sharrett, RF Gottesman Alzheimer's Research & Therapy 16 (1), 100, 2024 | | 2024 |
| Rethinking Blood Pressure Treatment and Dementia Risk in Older Adults: Is Adherence the Holy Grail? CB Wright, M Egle Journal of the American College of Cardiology 83 (13), 1204-1206, 2024 | | 2024 |
| Sex Differences in the Role of Multimorbidity on Poststroke Disability: The Taiwan Stroke Registry M Egle, WC Wang, YC Fann, MC Johansen, JT Lee, CH Yeh, ... Neurology 102 (5), e209140, 2024 | | 2024 |
| Abstract WMP15: Do Changes in Blood Brain Barrier Permeability Mediate the Association Between White Matter Hyperintensities and Post-Stroke Clinical Outcome? D Okine, K Kern, M Egle, ML Luby, L Latour, RF Gottesman Stroke 55 (Suppl_1), AWMP15-AWMP15, 2024 | | 2024 |
| Abstract TP35: A 2-Stage Recruitment Design to Reduce MRI Screening Costs for a Theoretical Clinical Trial of WMH Progression M Egle, M Power, JA Deal, CR Jack, KJ Sullivan, TH Mosley, ... Stroke 55 (Suppl_1), ATP35-ATP35, 2024 | | 2024 |
| Abstract WMP29: Sex Differences On The Importance Of Multimorbidity In Post-stroke Disability: the Taiwan Stroke Registry M Egle, WC Wang, YC Fann, RF Gottesman, ... Stroke 54 (Suppl_1), AWMP29-AWMP29, 2023 | | 2023 |
| Association Between Cerebral Small Vessel Disease, Blood Brain Barrier Disruption, and Outcome After Stroke DN Okine, K Kern, M Luby, M Egle, RF Gottesman ANNALS OF NEUROLOGY 92, S65-S65, 2022 | | 2022 |
| Does contrast-enhancement improve visualisation of lenticulostriate arteries in cerebral small vessel disease using time-of-flight magnetic resonance angiography at 7 Tesla? CN Osuafor, C Rua, AD Mackinnon, M Egle, P Benjamin, DJ Tozer, ... medRxiv, 2022.03. 23.22272852, 2022 | | 2022 |
| Evaluating Magnetic Resonance Imaging and Serum Markers As Surrogate Endpoints for Clinical Trials in Cerebral Small Vessel Disease M Egle | | 2021 |
Hugh MarkusProfessor of Stroke Medicine and Honorary Consultant Neurologist, University of CambridgeVerified email at medschl.cam.ac.uk
